BTI
DMAC icon

Blue Trust Inc’s DiaMedica Therapeutics DMAC Stock Holding History

Blue Trust Inc’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$468K Hold
69,122
– – 0.01% 500
2025
Q4 		$550K Hold
69,122
– – 0.01% 453
2025
Q3 		$475K Hold
69,122
– – 0.01% 510
2025
Q2 		$270K Hold
69,122
– – ﹤0.01% 660
2025
Q1 		$262K Hold
69,122
– – ﹤0.01% 619
2024
Q4 		$375K Buy
69,122
+24,875
+56% +$117K ﹤0.01% 455
2024
Q3 		$131K Buy
+44,247
New +$163K ﹤0.01% 1078

Other funds holding DMAC

CLG
Cooperman Leon G $3.05B AUM 42.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAPAIJV
Paragon Associates & Paragon Associates II Joint Venture Dallas, Texas $73.6M AUM 61.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Blue Trust Inc's DMAC Position: Q1 2026 in Review

Blue Trust Inc held its DiaMedica Therapeutics (DMAC) position steady in Q1 2026 at 69,122 shares worth $468K. The position accounts for 0.01% of the portfolio, ranked #500.

Blue Trust Inc first reported a position in DMAC in Q3 2024 and has held it in 7 quarters since. The position peaked at $550K in Q4 2025. 98 funds tracked by Wall St. Rank hold DMAC as of Q1 2026.

  • Blue Trust Inc held 69,122 shares of DiaMedica Therapeutics worth $468K as of Q1 2026.
  • Blue Trust Inc left its DiaMedica Therapeutics share count unchanged in Q1 2026.
  • DiaMedica Therapeutics made up 0.01% of Blue Trust Inc's portfolio in Q1 2026, its #500 holding.
  • Blue Trust Inc first reported a position in DiaMedica Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • Blue Trust Inc's DiaMedica Therapeutics position peaked at $550K in Q4 2025.
  • 98 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q1 2026.

Based on Blue Trust Inc's 13F filing for Q1 2026, filed 20 Apr 2026.